Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice
Mice deficient for the cellular prion protein (PrPC) do not develop prion disease; accordingly, gene-based strategies to diminish PrPC expression are of interest. We synthesized a series of chemically modified antisense oligonucleotides (ASOs) targeted against mouse Prnp messenger RNA (mRNA) and ide...
Main Authors: | Karah Nazor Friberg, Gene Hung, Ed Wancewicz, Kurt Giles, Chris Black, Sue Freier, Frank Bennett, Stephen J DeArmond, Yevgeniy Freyman, Pierre Lessard, Sina Ghaemmaghami, Stanley B Prusiner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116300671 |
Similar Items
-
Continuous quinacrine treatment results in the formation of drug-resistant prions.
by: Sina Ghaemmaghami, et al.
Published: (2009-11-01) -
Evidence that bank vole PrP is a universal acceptor for prions.
by: Joel C Watts, et al.
Published: (2014-04-01) -
Decreased MK-801 Binding in Discrete Hippocampal Regions of Prion-Infected Mice
by: M. Diez, et al.
Published: (2001-08-01) -
Influence of complexes of antisense-oligonucleotides with polymeric carriers on content of cellular prion in rat organs
by: N. U. Susol
Published: (2017-03-01) -
Protease-resistant prions selectively decrease Shadoo protein.
by: Joel C Watts, et al.
Published: (2011-11-01)